Unlock the Next Breakthrough in Cancer Therapy with Genetic Mutations at BIOMEX, we are leading the way in precision medicine, leveraging advanced genetic testing to drive the discovery and development of tailored therapies.

Our repository, comprising over 3,000,000 FFPE blocks, coupled with our validated mass spectrometry-based system, enables faster detection of up to 96 mutations across seven pivotal genes: BRAF, EGFR, ERBB2, KRAS, NRAS, PIK3CA, and POLE. These mutations are critical in influencing treatment efficacy and drug response, making our multiplex panel essential for personalized treatment strategies.

Mass spectrometry offers higher sensitivity, making it a more cost-effective solution that provides more detailed information compared to other techniques. This ensures precise detection and quantification of genetic mutations, enhancing the accuracy and reliability of our tests. In addition to our comprehensive multiplex panel, we offer customizable panels that can be tailored to specific mutations or genes, ensuring maximum flexibility and precision in genetic testing. We offer mass spectrometry services that provide researchers with the most advanced tools for genetic analysis.

By integrating mass spectrometry technologies, we aim to drive innovation in genomics and improve outcomes for patients through personalized medicine.

Contact us at sales@biomex.de to learn more about how our genetic tests can support your research. Together, we are committed to advancing precision oncology and combating cancer.